The Discounted Cash Flow (DCF) valuation of Jiangxi Fushine Pharmaceutical Co Ltd (300497.SZ) is (10.64) CNY. With the latest stock price at 9.62 CNY, the upside of Jiangxi Fushine Pharmaceutical Co Ltd based on DCF is -210.6%.

Is 300497.SZ a buy or a sell?

Based on the latest price of 9.62 CNY and our DCF valuation, Jiangxi Fushine Pharmaceutical Co Ltd (300497.SZ) is a sell. Selling 300497.SZ stocks now will result in a potential gain of 210.6%.

Note: valuation result may not be accurate due to the company's negative earnings.

	Range	Selected
WACC / Discount Rate	8.5% - 11.2%	9.8%
Long-term Growth Rate	3.0% - 5.0%	4.0%
Fair Price	(15.46) - (8.54)	(10.64)
Upside	-260.8% - -188.8%	-210.6%

9.62 CNY

Stock Price

(10.64) CNY

Fair Price

REVENUE & EXPENSES

CAPEX

D&A

WORKING CAPITAL

TERMINAL VALUE

300497.SZ DCF Valuation: Revenue & Expenses Forecast

(CNY in millions)		Projections

	12-2024	12-2025	12-2026	12-2027	12-2028	12-2029

Revenue	1,178	1,114	1,509	1,920	2,181	2,356
% Growth	27%	-5%	35%	27%	14%	8%

Cost of goods sold	(1,121)	(1,008)	(1,296)	(1,567)	(1,691)	(1,736)
% of Revenue	95%	90%	86%	82%	78%	74%

Selling, G&A expenses	(131)	(124)	(168)	(214)	(243)	(263)
% of Revenue	11%	11%	11%	11%	11%	11%

Research & Development	(65)	(62)	(84)	(107)	(121)	(131)
% of Revenue	6%	6%	6%	6%	6%	6%

Net interest & other expenses	(148)	(140)	(190)	(242)	(274)	(296)
% of Revenue	13%	13%	13%	13%	13%	13%

Tax expense	8	33	34	31	22	10
Tax rate	-3%	15%	15%	15%	15%	15%

Net profit	(280)	(187)	(195)	(178)	(127)	(59)
% Margin	-24%	-17%	-13%	-9%	-6%	-3%